Emergent CDMO is dedicated to helping pharma and biotech innovators bring life-saving, life-extending therapies to patients throughout the world. We have supported the development and manufacture of over 40 commercial and more than 200 clinical programs for our partners.

As a dedicated and experienced global CDMO solutions provider, we can support preclinical to commercial production of therapeutics and vaccines. Our clients benefit from Emergent CDMO’s diverse technology platforms, customizable solutions, infrastructure, and capabilities to support the clinical and commercial successes of their molecules.

Whether you’re looking for initial process development support, small volumes of material for clinical trials, or large-scale production for a global commercial therapy, our experienced CDMO team is ready to serve as your trusted guide from molecule to market.